Why these 3 ASX shares are in trading halts today

ResApp Health Ltd (ASX:RAP) shares are one of three missing out on the market meltdown due to being in trading halts. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The market is in selloff mode again on Tuesday with heavy declines being seen across the board.

Fortunately for the shares listed below, they are missing out on today's mini meltdown due to being in trading halts.

Here's why they have been halted:

LandMark White Limited (ASX: LMW)

The shares of this independent valuation and property consultancy company's shares were placed in a trading halt on Monday pending an announcement relating to a new acquisition. This morning the company revealed that it intends to acquire industry peer Taylor Byrne for a total consideration of $10.3 million. This will be payable as $5.15 million in cash and approximately 8.6 million of the company's shares valued at 60 cents each. According to management, the acquisition is expected to allow for revenue growth between the two companies. It also believes the deal to provide material benefit to both sets of shareholders, whilst delivering a platform for further growth in market share.

MGC Pharmaceuticals Ltd (ASX: MXC)

This diversified cannabis company requested a trading halt pending the release of an announcement regarding its Therapeutic Goods Administration (TGA) authorised prescriber application for use of CannEpil in Australia. CannEpil is CBD-based medication that is used as a treatment for people with refractory epilepsy. If the announcement reveals that CannEpil has been approved then it could be great news for the company. Especially given the recent appointment of Assoc. Professor Wendyl D'Souza to the MGC Pharmaceuticals Medical Advisory board. Mr D'Souza is an authorised prescriber of medicinal cannabis and has over 3,000 registered patients with drug resistant epilepsy from currently available anti-epilepsy medications.

ResApp Health Ltd (ASX: RAP)

ResApp Health shares were placed in a trading halt this morning pending the release of an announcement relating to its sleep apnoea clinical study. The digital health company has been running a double-blind, in-laboratory sleep apnoea clinical study with 600 patients in Perth. The study is testing a sound-based algorithm that identifies moderate and severe obstructive sleep apnoea using a smartphone placed on a bedside table. Management believes there is "a large clinical need for reducing the number of people with undiagnosed sleep apnoea and a scalable, accurate and easy to use smartphone-based screening test could significantly improve the health of a large portion of the adult population." All eyes will be on these results when they are announced in the coming days.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Share Market News

Why Calix, Collins Foods, Myer, and Patriot Battery Metals shares are charging higher

The S&P/ASX 200 Index (ASX: XJO) is back on form and charging higher on Tuesday. In afternoon trade, the benchmark index…

Read more »

Man in yellow hard hat looks through binoculars as man in white hard hat stands behind him and points.

Are Fortescue shares a contrarian buy after falling 20% in a month?

Are investors putting too much weight on the jitters of the market or is the Fortescue fall fair?

Read more »

A young woman wearing a blue and white striped t-shirt blows air from her cheeks and looks up and to the side in a sign of disappointment after the ASX shares she owns went down today
Share Fallers

Why DroneShield, Paladin Energy, Red 5, and Synlait shares are falling

These shares are having a tough time on Tuesday. But why?

Read more »

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
Bank Shares

Nine-year highs: NAB share price glides to highest level since 2015!

The bank has notched up another inflection point today.

Read more »

ANZ ASX 200 banks capital return Group of investors madly grabbing for cash on city street.
Healthcare Shares

ResMed shares rebounding as investors rush to buy the dip

ResMed is rising as ASX investors buy the dip following yesterday's 13% share price dive.

Read more »

A woman screams and holds her hands up in frustration.
Share Market News

Why is short interest in Sayona Mining shares growing?

Why won't short sellers leave this lithium miner alone?

Read more »

A woman in a bright yellow jumper looks happily at her yellow piggy bank representing bank dividends and in particular the CBA dividend
Bank Shares

CBA shares hit another new high! Too late to buy?

At today's new record price, CBA's market capitalisation is just $1 billion short of the ASX 200's most valuable stock,…

Read more »

A group of stockbrokers sit in a room with several computer screens in front of them as they discuss the Zip share price and Zip's merger with Sezzle
Broker Notes

Why these 3 ASX 200 shares just gained significant broker upgrades

The brokers just boosted their outlooks for these ASX 200 shares. But why?

Read more »